Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Soichi Fumita's publication output changed over time?
ScholarIQpublication output · 2011–2021
Output declined50% over the shown period — from 2 works in 2011 to 1 in 2021.
2
2
1
2
3
1
201120152018201920202021
What are the most-cited papers on Soichi Fumita?
ScholarIQmost cited works
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Narikazu Boku, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Keiko Minashi, K.-W. Lee, H. Cho, Won Ki Kang, Yoshito Komatsu, Masahiro Tsuda, Kensei Yamaguchi, Hiroki Hara, Soichi Fumita, Mizutomo Azuma, L.-T. Chen, Yoon‐Koo Kang
Annals of Oncology. 2018325 CitationsOPEN ACCESS
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
Masayuki Takeda, Takayuki Takahama, Kazuko Sakai, Shigeki Shimizu, Satomi Watanabe, Hisato Kawakami, Kaoru Tanaka, Chihiro Sato, Hidetoshi Hayashi, Yoshikane Nonagase, Kimio Yonesaka, Naoki Takegawa, Tatsuya Okuno, Takeshi Yoshida, Soichi Fumita, Shinichiro Suzuki, Koji Haratani, Kazumasa Saigoh, Akihiko Ito, Tetsuya Mitsudomi, Hisashi Handa, Kazuya Fukuoka, Kazuhiko Nakagawa, Kazuto Nishio
The Oncologist. 202097 CitationsOPEN ACCESS
Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
Junko Tanizaki, Isamu Okamoto, Soichi Fumita, Wataru Okamoto, Kazuto Nishio, Kazuhiko Nakagawa
S128439998. 201169 Citations
Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
Akihiro Tokoro, Hisao Imai, Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Yusaku Akashi, Hiroki Sato, Yoshiyuki Kizawa
Cancer Medicine. 201949 CitationsOPEN ACCESS
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
Yasuhiro Kidera, Taroh Satoh, Shinya Ueda, Wataru Okamoto, Isamu Okamoto, Soichi Fumita, Kimio Yonesaka, Hidetoshi Hayashi, Chihiro Makimura, Kunio Okamoto, Hidemi Kiyota, Junji Tsurutani, Masaki Miyazaki, Masahiro Yoshinaga, Kimiko Fujiwara, Yuzuru Yamazoe, Kenzo Moriyama, Masanobu Tsubaki, Yasutaka Chiba, Shozo Nishida, Kazuhiko Nakagawa
International Journal of Clinical Oncology. 201142 Citations
Related on ScholarIQ
Kishiwada City Hospital
Institution
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Paper
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
Paper
Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
Paper
Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
Paper
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
Paper